Zydus Lifesciences Limited has announced its participation in the Bank of America India Conference, scheduled to take place in Mumbai on June 2, 2026. The conference serves as a vital platform for the company to engage with institutional investors and the broader financial community.

Conference Participation Details

The following details have been disclosed regarding the upcoming event:

Zydus Lifesciences Limited's involvement in the Bank of America India Conference underscores its ongoing commitment to maintaining transparency and dialogue with the investment community. The company has not provided specific details regarding the agenda or presentation topics for the event.

Zydus Lifesciences Limited has released the public announcement for its buyback of equity shares worth ₹1,100 crore. The company will repurchase up to 95,65,217 fully paid-up equity shares, representing 0.95% of the total paid-up equity share capital, at a price of ₹1,150 per share. The transaction will be conducted via the tender offer route using the stock exchange mechanism.

The Board has fixed May 29, 2026, as the record date to determine shareholder eligibility. The tender period for the offer is scheduled to commence on June 4, 2026, and will remain open for five working days until June 10, 2026. The buyback size constitutes 5.16% and 3.84% of the aggregate of the fully paid-up equity share capital and free reserves as per the latest audited standalone and consolidated financial statements as of March 31, 2026, respectively.

Buyback Details

The key parameters of the buyback are outlined below:

Shareholding Pattern

The pre-buyback shareholding pattern indicates a strong promoter holding. The promoter and promoter group hold 74.99% of the total equity shares.

The company has appointed ICICI Securities Limited as the manager to the buyback and MUFG Intime India Private Limited as the registrar. The public announcement was published in leading newspapers on May 21, 2026.